Table 1.
Characteristics of patients.
| Parameters | Mean/percentage |
|---|---|
| Sex | |
| (Male) | 46% (88/190) |
| (Female) | 54% (102/190) |
| Age at diagnosis | 69 ± 10 |
| ISS stage | |
| Stage I | 22% (41/190) |
| Stage II | 26% (49/190) |
| Stage III | 52% (100/190) |
| Isotype | |
| IgA k | 15% (28/190) |
| IgA λ | 15% (28/190) |
| IgG k | 37% (71/190) |
| IgG λ | 20% (36/190) |
| Light chain k | 6% (13/190) |
| Light chain λ | 7% (14/190) |
| LDH U/L (normal range 50–250) | 193 ± 91 |
| Serum calcium mg/dL (normal range 8.6–10.21) | 9.57 ± 1.03 |
| Serum creatinine mg/dL (normal range 0.51–0.95) | 1.55 ± 1.58 |
| Monoclonal Component g/L | 26.01 ± 20.42 |
| Serum albumin g/L (normal range 35–52) | 35.1 ± 6.39 |
| β-2 Microglobulin mg/L (normal range 0.8–2.2) | 7.50 ± 7.78 |
| Bone marrow plasma cells (%) | 45 ± 26 |
| Hemoglobin g/dL (normal range 12–16 l) | 11.11 ± 6.14 |
| Hematocrit % (normal range 35–48) | 32 ± 5.70 |
| MCV fL (normal range 80–99) | 91.83 ± 8.36 |
| RDW-CV% (normal range 11–15) | 15.77 ± 2.68 |